Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2Phase 1/2 2Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1Inflammatory Bowel Diseases 1Diverticulitis 1Diverticular Diseases 1Colonic Neoplasms 1Agnosia 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 154Carboplatin 146Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 118Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Passive Cutaneous Anaphylaxis × Clear all
NCT01477190 2011-11-28

Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 1/2 Completed
40 enrolled
Gastrointestinal

Colonic Neoplasms, Diverticulitis, Inflammatory Bowel Diseases

NCT00747292 2008-09-05

Peri-Operative Management of Patients Undergoing Laparoscopic Colorectal Surgery

Minimal Access Therapy Training Unit

Phase 1/2 Unknown
99 enrolled

Diverticular Diseases, Agnosia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡